These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 16124948)

  • 1. Formulation development and stability testing of oral morphine solution utilizing preformulation approach.
    Preechagoon D; Sumyai V; Tontisirin K; Aumpon S; Pongjanyakul T
    J Pharm Pharm Sci; 2005 Aug; 8(2):362-9. PubMed ID: 16124948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of an extemporaneously compounded baclofen oral liquid.
    Johnson CE; Hart SM
    Am J Hosp Pharm; 1993 Nov; 50(11):2353-5. PubMed ID: 8266961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of sulfadiazine oral liquids prepared from tablets and powder.
    Pathmanathan U; Halgrain D; Chiadmi F; Schlatter J; Vermerie N
    J Pharm Pharm Sci; 2004 Apr; 7(1):84-7. PubMed ID: 15144740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical stability of oseltamivir in oral solutions.
    Albert K; Bockshorn J
    Pharmazie; 2007 Sep; 62(9):678-82. PubMed ID: 17944321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of cefuroxime in 1% and 5% buffered eye drops determined with HPLC method.
    Kodym A; Wiśniewski A; Knioła D; Olejniczak M
    Acta Pol Pharm; 2011; 68(4):555-64. PubMed ID: 21796938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of levamisole oral solutions prepared from tablets and powder.
    Chiadmi F; Lyer A; Cisternino S; Toledano A; Schlatter J; Ratiney R; Fontan JE
    J Pharm Pharm Sci; 2005 Aug; 8(2):322-5. PubMed ID: 16124942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis.
    Bozdağ S; Gümüş K; Gümüş O; Unlü N
    Eur J Pharm Biopharm; 2008 Sep; 70(1):260-9. PubMed ID: 18590953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation development and manufacturing of a gastrin/CCK-2 receptor targeting peptide as an intermediate drug product for a clinical imaging study.
    Sosabowski JK; Lee M; Dekker BA; Simmons BP; Singh S; Beresford H; Hagan SA; McKenzie AJ; Mather SJ; Watson SA
    Eur J Pharm Sci; 2007 Jun; 31(2):102-11. PubMed ID: 17387005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of compounding and storage conditions on stability of pergolide mesylate.
    Davis JL; Kirk LM; Davidson GS; Papich MG
    J Am Vet Med Assoc; 2009 Feb; 234(3):385-9. PubMed ID: 19210262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of an alternative extemporaneous captopril fast-dispersing tablet formulation versus an extemporaneous oral liquid formulation.
    Pabari RM; McDermott C; Barlow J; Ramtoola Z
    Clin Ther; 2012 Nov; 34(11):2221-9. PubMed ID: 23149007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevant shaking stress conditions for antibody preformulation development.
    Eppler A; Weigandt M; Hanefeld A; Bunjes H
    Eur J Pharm Biopharm; 2010 Feb; 74(2):139-47. PubMed ID: 19922795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of reconstituted fluconazole oral suspension in plastic bottles and oral syringes.
    Dentinger PJ; Swenson CF
    Ann Pharmacother; 2009 Mar; 43(3):485-9. PubMed ID: 19208778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of in vivo efficacy of topical formulations containing soybean extract.
    Georgetti SR; Casagrande R; Verri WA; Lopez RF; Fonseca MJ
    Int J Pharm; 2008 Mar; 352(1-2):189-96. PubMed ID: 18079076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and in vitro evaluation of a cosmetic emulsion from almond oil.
    Akhtar N; Ahmad M; - G; Masood MI; Aleem M
    Pak J Pharm Sci; 2008 Oct; 21(4):430-7. PubMed ID: 18930867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of primary packaging on the quality of parenteral products.
    Solomun L; Ibric S; Boltic Z; Djuric Z; Stupar B
    J Pharm Biomed Anal; 2008 Nov; 48(3):744-8. PubMed ID: 18786797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of parenteral midazolam in an oral formulation.
    Walker SE; Grad HA; Haas DA; Mayer A
    Anesth Prog; 1997; 44(1):17-22. PubMed ID: 9481976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of in silico models for estimating drug preformulation risk in PEG400/water and Tween80/water systems.
    Crivori P; Morelli A; Pezzetta D; Rocchetti M; Poggesi I
    Eur J Pharm Sci; 2007 Nov; 32(3):169-81. PubMed ID: 17714921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and in vitro evaluation of a controlled release formulation to produce wide dose interval morphine tablets.
    Holgado MA; Iruin A; Alvarez-Fuentes J; Fernández-Arévalo M
    Eur J Pharm Biopharm; 2008 Oct; 70(2):544-9. PubMed ID: 18588973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of dilute oral morphine solution for neonatal abstinence syndrome.
    Sauberan J; Rossi S; Kim JH
    J Addict Med; 2013; 7(2):113-5. PubMed ID: 23370932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of formulation properties on chemical stability of captopril in aqueous preparations.
    Kristensen S; Lao YE; Brustugun J; Braenden JU
    Pharmazie; 2008 Dec; 63(12):872-7. PubMed ID: 19177902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.